marijuana stock news

Vapor Hub International Inc. (VHUB)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 1,127   1,372   803   400  
Cost of Revenue 670 743 455 193
Gross Profit 457   628   349   207  
Operating Expenses
Research Development – – – –
Selling General and Administrative 647 583 751 233
Non Recurring – – – –
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (190) 45   (403) (27)
Income from Continuing Operations
Total Other Income/Expenses Net – – – –
Earnings Before Interest And Taxes (190) 45 (409) 3
Interest Expense – – 11 –
Income Before Tax (190) 45 (420) 3
Income Tax Expense – 1 – 7
Minority Interest – – – –
Net Income From Continuing Ops (190) 44 (420) (4)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (190) 44   (420) (4)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (190) 44   (420) (4)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The Alkaline Water Company Inc. (WTER.V) (WTER) Announces Pricing of Public Offering of Common Stock

The Alkaline Water Company Inc. Announces Pricing of Public Offering of Common…

MariMed Inc. (MRMD) Commences Wholesale Operations in Missouri

MariMed Commences Wholesale Operations in Missouri MariMed Inc. (“MariMed” or the “Company”)…

Tilray, Inc. (TLRY) Aphria RX GmbH Subsidiary Completes First Successful Harvest

Tilray’s Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of…

INSYS Therapeutics, Inc. (INSY) Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution

INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution…